(C) Reuters. Traders wearing masks work, on the first day of in person trading since the closure during the outbreak of the coronavirus disease (COVID-19) on the floor at the NYSE in New York
By Devik Jain
(Reuters) – The S&P 500 and the Dow inched lower on Friday, extending their longest losing spree in a year as fears about the outlook for the economy in a future still dominated by the coronavirus weighed on investor sentiment.
Five of the 11 major S&P indexes fell in early trading, with a 0.7% drop for energy stocks (SPNY) putting them on course for one of their worst weeks since the coronavirus-driven crash in March.
The defensive real estate sector <.splrcr> led gains among those trading higher.</.splrcr>
A clutch of mixed macroeconomic data has weighed on Wall Street in recent weeks, overshadowing signs of progress on Congressional stimulus that, analysts say, is needed to sustain an economic recovery.
“There’s evidence of a slowdown in the United States, which we think is temporary, but it would be reinforced if there is no additional fiscal package,” said Sebastien Galy, senior macro strategist at Nordea Asset Management in Luxembourg.
The S&P 500 is on course for its fourth straight weekly decline – its longest losing streak since August 2019 – and is hovering just above correction territory with investors oscillating between beaten-down technology-related shares and value-linked sectors such as industrials.
The S&P industrials sector (SPLRCI) added 0.2% as data showed new orders for key U.S.-made capital goods increased more than expected in August.
Analysts warned the CBOE volatility index (VIX), known as Wall Street’s fear gauge, could climb higher toward the end of the quarter next week as well as the Nov. 3 presidential election.
Costco Wholesale Corp (O:COST) fell 2.6% as the warehouse chain recorded high coronavirus-related costs for the second straight quarter.
Boeing Co (N:BA) gained 2.4% after Europe’s chief aviation safety regulator said the planemaker’s grounded 737 MAX could receive regulatory approval to resume flying in November and enter service by the end of the year.
Novavax Inc (O:NVAX) jumped 9.8% after the drugmaker launched a late-stage trial of its experimental COVID-19 vaccine in the UK.
Advancing issues nearly matched decliners on the NYSE and outnumbered them 1.68-to-1 on the Nasdaq.
The S&P index recorded no new 52-week high or low, while the Nasdaq recorded seven new highs and 23 new lows.
S&P 500, Dow extend longest losing spree in a year
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.